Phenylbutynamine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Phenylbutynamine (4-phenylbut-3-yn-2-amine; development code PAL-874) is a monoamine releasing agent (MRA) of the arylalkylamine family related to β-phenethylamine and amphetamine.[1] It acts as a norepinephrine–dopamine releasing agent (NDRA), albeit with far lower potency than β-phenethylamine or amphetamine.[1][2]
Other names4-Phenylbut-3-yn-2-amine; PAL-874; PAL874
| Clinical data | |
|---|---|
| Other names | 4-Phenylbut-3-yn-2-amine; PAL-874; PAL874 |
| Drug class | Norepinephrine–dopamine releasing agent[1] |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C10H11N |
| Molar mass | 145.205 g·mol−1 |
| 3D model (JSmol) | |
| |
| |